Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | 211,100 | reported | 29 Sept 2025 | tx 7+1,797,499−30,669 |
| Garrett Motion Inc. | 0 | reported | 06 Jun 2023 | tx 2+16,592,384−16,592,384 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Sept 2025 | EXERCISE | SAB Biotherapeutics, Inc. | 1,740,000 | 1.75 USD | |
| 29 Sept 2025 | EXERCISE | SAB Biotherapeutics, Inc. | 17,400 | — | deriv |
| 10 Nov 2023 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 13,269 | — | deriv |
| 10 Nov 2023 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 8,846 | — | deriv |
| 10 Nov 2023 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 22,115 | — | deriv |
| 13 Nov 2023 | EXERCISE | SAB Biotherapeutics, Inc. | 13,269 | — | deriv |
| 13 Nov 2023 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 13,269 | 1000.00 USD | deriv |
| 06 Jun 2023 | EXERCISE | Garrett Motion Inc. | 16,592,384 | — | |
| 06 Jun 2023 | EXERCISE | Garrett Motion Inc. | 16,592,384 | 0.00 USD | deriv |